Cargando…

Clinical use of pharmacogenomics

Detalles Bibliográficos
Autor principal:	Telenti, Amalio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360252/ http://dx.doi.org/10.1186/1742-4690-9-S1-I2

Ejemplares similares

Host genome influences on susceptibility to HIV-1
por: Telenti, Amalio
Publicado: (2009)

Pharmacogenomics of cardiovascular drugs
por: Adithan, C
Publicado: (2014)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

Using economic modelling to contribute to the prioritisation and design and clinical trials: ready for prime time
por: Sculpher, Mark
Publicado: (2011)

Clinical impact of food processing
por: Baumert, Joseph
Publicado: (2011)

Immunological and clinical effects of probiotics
por: Eigenmann, Philippe
Publicado: (2011)

The clinical picture and outcome in adults
por: Elewaut, Dirk
Publicado: (2014)

Spondyloarthritis - the clinical picture in children
por: Vargas, Ruben Burgos
Publicado: (2014)

Seven myths of randomisation in clinical trials
por: Senn, Stephen
Publicado: (2011)

Clinical utility of thresholds versus CRD
por: Bindslev-Jensen, Carsten
Publicado: (2011)

The heel fat pad: mechanical properties and clinical applications
por: Wearing, Scott C, et al.
Publicado: (2011)

Peach allergy: different clinical profiles across Europe
por: Fernandez-Rivas, Montserrat
Publicado: (2011)

Next-generation clinical sequencing in a children’s hospital
por: Kingsmore, Stephen
Publicado: (2011)

Science in a crisis: conducting clinical trials in an emergency
por: Horby, P
Publicado: (2015)

Clinical thresholds in food allergy and their application in risk assessment management
por: Houben, Geert
Publicado: (2011)

Are clinical genomes already becoming semi-routine for patient care?
por: Boguski, Mark
Publicado: (2011)

The UK Medical Research Council and clinical trials, 1934-1960
por: Chalmers, Iain
Publicado: (2013)

PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
por: Aksentijevich, I
Publicado: (2013)

When to decide to enroll a TTR-FAP patient in a Clinical Trial?
por: Buades, Juan
Publicado: (2015)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Recipes for use in DBPCFC and the importance of blinding
por: Vlieg-Boerstra, Berber, et al.
Publicado: (2011)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

Protein or no protein? Using PCR for detecting allergens in foods
por: Röder, Martin, et al.
Publicado: (2011)

Transporters used by parasites as drug targets: tempting but underexploited
por: Staines, Henry
Publicado: (2010)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

Proposed requirements for hypoallergenic formulae to be used in the treatment and prevention of cow's milk allergy
por: Muraro, Antonella
Publicado: (2011)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

Gene discovery for complex diseases using exomic sequencing: identifying pancreatic cancer susceptibility genes
por: Klein, Alison P
Publicado: (2010)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

Implementation of Casemix system in Hospital Universiti Sains Malaysia by using UNU-CBG grouper: is it feasible to support apex programme?
por: Mohamad, Rosminah
Publicado: (2012)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ha5fg4l15knl5gemi98luvc94s